Aromatic hydrocarbon receptor polymorphism: Development of new methods to correlate genotype with phenotype

被引:25
作者
Maier, A
Micka, J
Miller, K
Denko, T
Chang, CY
Nebert, DW
Puga, A
机构
[1] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Ctr Environm Genet, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA
[3] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA
关键词
aromatic hydrocarbon (Ah) receptor; mouse Ahr gene polymorphism; oligonucleotide hybridization; yeast two-hybrid system; beta-naphthoflavone;
D O I
10.2307/3434070
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Differential CYP1A1 inducibility, reflecting variations in aromatic hydrocarbon receptor (AHR) affinity among inbred mouse strains, is an important determinant of environmental toxicity. We took advantage of the Ahr polymorphism in C57BL/6 and DBA/2 mice to develop an oligonucleotide-hybridization screening approach for the rapid identification of DNA sequence differences between Abr alleles. Oligonucleotides containing single-base changes at polymorphic sites were immobilized on a solid support and hybridized with C57BL/6 or DBA/2 AHR cDNA radiolabeled probes. The observed hybridization patterns demonstrate that this approach can be used to detect nucleotide differences in the Ahr coding region with very high accuracy. In parallel experiments, we used a yeast two-hybrid system to assess phenotypic differences in AHR function. AHR activation, as measured by P-galactosidase reporter activity in Saccharomyces cerevisiae strain SFY526, was determined following treatment with varying doses of the AHR ligand beta-naphthoflavone (BNF). We found that the C57BL/6 AHR has about a 15-fold higher affinity for BNF than the DBA/2 AHR, in much better agreement with results reported for whole-anima studies than the values observed by in vitro ligand-binding assays. Using C57BL/6 and DBA/2 AHR chimeric proteins, we also confirmed the previously reported observation that an A375V change is principally responsible for the high- to low-affinity AHR phenotype. There has been no straightforward method to reliably and reproducibly phenotype large numbers of humans for CYP1A1 inducibility or AHR affinity. Screening human AHR cDNAs by oligonucleotide-hybridization and yeast two-hybrid methodologies will be invaluable for the rapid and unequivocal determination of changes in DNA sequence and receptor-ligand affinities associated with human AHR polymorphisms.
引用
收藏
页码:421 / 426
页数:6
相关论文
共 46 条
[1]  
ATSDR (Agency for Toxic Substances and Disease Registry), 1997, TOX PROF CHLOR DIB P
[2]  
ATSDR - Agency for Toxic Substances and Disease Registry, 1995, TOX PROF POL AR HYDR
[3]   THE MECHANISM OF DIOXIN TOXICITY - RELATIONSHIP TO RISK ASSESSMENT [J].
BIRNBAUM, LS .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 :157-167
[4]   A METHOD FOR TYPING POLYMORPHISM AT THE HLA-A LOCUS USING PCR AMPLIFICATION AND IMMOBILIZED OLIGONUCLEOTIDE PROBES [J].
BUGAWAN, TL ;
APPLE, R ;
ERLICH, HA .
TISSUE ANTIGENS, 1994, 44 (03) :137-147
[5]   CLONING OF THE AH-RECEPTOR CDNA REVEALS A DISTINCTIVE LIGAND-ACTIVATED TRANSCRIPTION FACTOR [J].
BURBACH, KM ;
POLAND, A ;
BRADFIELD, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) :8185-8189
[6]  
CARVER LA, 1994, J BIOL CHEM, V269, P30109
[7]   10 NUCLEOTIDE DIFFERENCES, 5 OF WHICH CAUSE AMINO-ACID CHANGES, ARE ASSOCIATED WITH THE AH RECEPTOR LOCUS POLYMORPHISM OF C57BL/6 AND DBA/2 MICE [J].
CHANG, CY ;
SMITH, DR ;
PRASAD, VS ;
SIDMAN, CL ;
NEBERT, DW ;
PUGA, A .
PHARMACOGENETICS, 1993, 3 (06) :312-321
[8]   Constitutive activation of the aromatic hydrocarbon receptor [J].
Chang, CY ;
Puga, A .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (01) :525-535
[9]   DETECTION OF SICKLE-CELL BETA-S-GLOBIN ALLELE BY HYBRIDIZATION WITH SYNTHETIC OLIGONUCLEOTIDES [J].
CONNER, BJ ;
REYES, AA ;
MORIN, C ;
ITAKURA, K ;
TEPLITZ, RL ;
WALLACE, RB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (01) :278-282
[10]  
DOLWICK KM, 1993, MOL PHARMACOL, V44, P911